A psychiatric and nervous drug (psychiatric or psychotropic medication) is a psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system.
Mental health and well-being affect our daily lives. Psychotropic medications can be an important part of the tools available to help keep us well.
This report aims to provide a comprehensive presentation of the global market for Psychiatric and Nervous Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psychiatric and Nervous Drugs. This report contains market size and forecasts of Psychiatric and Nervous Drugs in global, including the following market information:
Global Psychiatric and Nervous Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Psychiatric and Nervous Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Psychiatric and Nervous Drugs companies in 2022 (%)
The global Psychiatric and Nervous Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Antidepressants Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Psychiatric and Nervous Drugs include Pfizer, Ely Lilly, Actavis, Mylan, Randox, Intellipharmaceutics, Astrazeneca, Lundbeck and Allergan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Psychiatric and Nervous Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psychiatric and Nervous Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, by Type, 2022 (%)
Antidepressants
Anti-anxiety
Antipsychotic
Mood Stabilizing
Stimulant Medications
Others
Global Psychiatric and Nervous Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Psychiatric and Nervous Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psychiatric and Nervous Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Psychiatric and Nervous Drugs revenues share in global market, 2022 (%)
Key companies Psychiatric and Nervous Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Psychiatric and Nervous Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Ely Lilly
Actavis
Mylan
Randox
Intellipharmaceutics
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Chengdu Kanghong Pharmaceutical
HUAHAI
Zhejiang Jianfeng
Beijing Winsunny Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psychiatric and Nervous Drugs, market overview.
Chapter 2: Global Psychiatric and Nervous Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Psychiatric and Nervous Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psychiatric and Nervous Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Psychiatric and Nervous Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Psychiatric and Nervous Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psychiatric and Nervous Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Psychiatric and Nervous Drugs Overall Market Size
2.1 Global Psychiatric and Nervous Drugs Market Size: 2022 VS 2029
2.2 Global Psychiatric and Nervous Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Psychiatric and Nervous Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Psychiatric and Nervous Drugs Players in Global Market
3.2 Top Global Psychiatric and Nervous Drugs Companies Ranked by Revenue
3.3 Global Psychiatric and Nervous Drugs Revenue by Companies
3.4 Global Psychiatric and Nervous Drugs Sales by Companies
3.5 Global Psychiatric and Nervous Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Psychiatric and Nervous Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Psychiatric and Nervous Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Psychiatric and Nervous Drugs Players in Global Market
3.8.1 List of Global Tier 1 Psychiatric and Nervous Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Psychiatric and Nervous Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Psychiatric and Nervous Drugs Market Size Markets, 2022 & 2029
4.1.2 Antidepressants
4.1.3 Anti-anxiety
4.1.4 Antipsychotic
4.1.5 Mood Stabilizing
4.1.6 Stimulant Medications
4.1.7 Others
4.2 By Type - Global Psychiatric and Nervous Drugs Revenue & Forecasts
4.2.1 By Type - Global Psychiatric and Nervous Drugs Revenue, 2018-2023
4.2.2 By Type - Global Psychiatric and Nervous Drugs Revenue, 2024-2029
4.2.3 By Type - Global Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Psychiatric and Nervous Drugs Sales & Forecasts
4.3.1 By Type - Global Psychiatric and Nervous Drugs Sales, 2018-2023
4.3.2 By Type - Global Psychiatric and Nervous Drugs Sales, 2024-2029
4.3.3 By Type - Global Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Psychiatric and Nervous Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Psychiatric and Nervous Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Psychiatric and Nervous Drugs Revenue & Forecasts
5.2.1 By Application - Global Psychiatric and Nervous Drugs Revenue, 2018-2023
5.2.2 By Application - Global Psychiatric and Nervous Drugs Revenue, 2024-2029
5.2.3 By Application - Global Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Psychiatric and Nervous Drugs Sales & Forecasts
5.3.1 By Application - Global Psychiatric and Nervous Drugs Sales, 2018-2023
5.3.2 By Application - Global Psychiatric and Nervous Drugs Sales, 2024-2029
5.3.3 By Application - Global Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Psychiatric and Nervous Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Psychiatric and Nervous Drugs Market Size, 2022 & 2029
6.2 By Region - Global Psychiatric and Nervous Drugs Revenue & Forecasts
6.2.1 By Region - Global Psychiatric and Nervous Drugs Revenue, 2018-2023
6.2.2 By Region - Global Psychiatric and Nervous Drugs Revenue, 2024-2029
6.2.3 By Region - Global Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Psychiatric and Nervous Drugs Sales & Forecasts
6.3.1 By Region - Global Psychiatric and Nervous Drugs Sales, 2018-2023
6.3.2 By Region - Global Psychiatric and Nervous Drugs Sales, 2024-2029
6.3.3 By Region - Global Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Psychiatric and Nervous Drugs Revenue, 2018-2029
6.4.2 By Country - North America Psychiatric and Nervous Drugs Sales, 2018-2029
6.4.3 US Psychiatric and Nervous Drugs Market Size, 2018-2029
6.4.4 Canada Psychiatric and Nervous Drugs Market Size, 2018-2029
6.4.5 Mexico Psychiatric and Nervous Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Psychiatric and Nervous Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Psychiatric and Nervous Drugs Sales, 2018-2029
6.5.3 Germany Psychiatric and Nervous Drugs Market Size, 2018-2029
6.5.4 France Psychiatric and Nervous Drugs Market Size, 2018-2029
6.5.5 U.K. Psychiatric and Nervous Drugs Market Size, 2018-2029
6.5.6 Italy Psychiatric and Nervous Drugs Market Size, 2018-2029
6.5.7 Russia Psychiatric and Nervous Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Psychiatric and Nervous Drugs Market Size, 2018-2029
6.5.9 Benelux Psychiatric and Nervous Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Psychiatric and Nervous Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Psychiatric and Nervous Drugs Sales, 2018-2029
6.6.3 China Psychiatric and Nervous Drugs Market Size, 2018-2029
6.6.4 Japan Psychiatric and Nervous Drugs Market Size, 2018-2029
6.6.5 South Korea Psychiatric and Nervous Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Psychiatric and Nervous Drugs Market Size, 2018-2029
6.6.7 India Psychiatric and Nervous Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Psychiatric and Nervous Drugs Revenue, 2018-2029
6.7.2 By Country - South America Psychiatric and Nervous Drugs Sales, 2018-2029
6.7.3 Brazil Psychiatric and Nervous Drugs Market Size, 2018-2029
6.7.4 Argentina Psychiatric and Nervous Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales, 2018-2029
6.8.3 Turkey Psychiatric and Nervous Drugs Market Size, 2018-2029
6.8.4 Israel Psychiatric and Nervous Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Psychiatric and Nervous Drugs Market Size, 2018-2029
6.8.6 UAE Psychiatric and Nervous Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Psychiatric and Nervous Drugs Major Product Offerings
7.1.4 Pfizer Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Ely Lilly
7.2.1 Ely Lilly Company Summary
7.2.2 Ely Lilly Business Overview
7.2.3 Ely Lilly Psychiatric and Nervous Drugs Major Product Offerings
7.2.4 Ely Lilly Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Ely Lilly Key News & Latest Developments
7.3 Actavis
7.3.1 Actavis Company Summary
7.3.2 Actavis Business Overview
7.3.3 Actavis Psychiatric and Nervous Drugs Major Product Offerings
7.3.4 Actavis Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Actavis Key News & Latest Developments
7.4 Mylan
7.4.1 Mylan Company Summary
7.4.2 Mylan Business Overview
7.4.3 Mylan Psychiatric and Nervous Drugs Major Product Offerings
7.4.4 Mylan Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Mylan Key News & Latest Developments
7.5 Randox
7.5.1 Randox Company Summary
7.5.2 Randox Business Overview
7.5.3 Randox Psychiatric and Nervous Drugs Major Product Offerings
7.5.4 Randox Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Randox Key News & Latest Developments
7.6 Intellipharmaceutics
7.6.1 Intellipharmaceutics Company Summary
7.6.2 Intellipharmaceutics Business Overview
7.6.3 Intellipharmaceutics Psychiatric and Nervous Drugs Major Product Offerings
7.6.4 Intellipharmaceutics Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Intellipharmaceutics Key News & Latest Developments
7.7 Astrazeneca
7.7.1 Astrazeneca Company Summary
7.7.2 Astrazeneca Business Overview
7.7.3 Astrazeneca Psychiatric and Nervous Drugs Major Product Offerings
7.7.4 Astrazeneca Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Astrazeneca Key News & Latest Developments
7.8 Lundbeck
7.8.1 Lundbeck Company Summary
7.8.2 Lundbeck Business Overview
7.8.3 Lundbeck Psychiatric and Nervous Drugs Major Product Offerings
7.8.4 Lundbeck Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Lundbeck Key News & Latest Developments
7.9 Allergan
7.9.1 Allergan Company Summary
7.9.2 Allergan Business Overview
7.9.3 Allergan Psychiatric and Nervous Drugs Major Product Offerings
7.9.4 Allergan Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Allergan Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Psychiatric and Nervous Drugs Major Product Offerings
7.10.4 GSK Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.10.5 GSK Key News & Latest Developments
7.11 Otsuka Pharmaceutical
7.11.1 Otsuka Pharmaceutical Company Summary
7.11.2 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Business Overview
7.11.3 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Major Product Offerings
7.11.4 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Otsuka Pharmaceutical Key News & Latest Developments
7.12 Takeda
7.12.1 Takeda Company Summary
7.12.2 Takeda Psychiatric and Nervous Drugs Business Overview
7.12.3 Takeda Psychiatric and Nervous Drugs Major Product Offerings
7.12.4 Takeda Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Takeda Key News & Latest Developments
7.13 NHU Group
7.13.1 NHU Group Company Summary
7.13.2 NHU Group Psychiatric and Nervous Drugs Business Overview
7.13.3 NHU Group Psychiatric and Nervous Drugs Major Product Offerings
7.13.4 NHU Group Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.13.5 NHU Group Key News & Latest Developments
7.14 Shionogi
7.14.1 Shionogi Company Summary
7.14.2 Shionogi Business Overview
7.14.3 Shionogi Psychiatric and Nervous Drugs Major Product Offerings
7.14.4 Shionogi Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Shionogi Key News & Latest Developments
7.15 APOTEX
7.15.1 APOTEX Company Summary
7.15.2 APOTEX Business Overview
7.15.3 APOTEX Psychiatric and Nervous Drugs Major Product Offerings
7.15.4 APOTEX Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.15.5 APOTEX Key News & Latest Developments
7.16 Chengdu Kanghong Pharmaceutical
7.16.1 Chengdu Kanghong Pharmaceutical Company Summary
7.16.2 Chengdu Kanghong Pharmaceutical Business Overview
7.16.3 Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Major Product Offerings
7.16.4 Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Chengdu Kanghong Pharmaceutical Key News & Latest Developments
7.17 HUAHAI
7.17.1 HUAHAI Company Summary
7.17.2 HUAHAI Business Overview
7.17.3 HUAHAI Psychiatric and Nervous Drugs Major Product Offerings
7.17.4 HUAHAI Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.17.5 HUAHAI Key News & Latest Developments
7.18 Zhejiang Jianfeng
7.18.1 Zhejiang Jianfeng Company Summary
7.18.2 Zhejiang Jianfeng Business Overview
7.18.3 Zhejiang Jianfeng Psychiatric and Nervous Drugs Major Product Offerings
7.18.4 Zhejiang Jianfeng Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Zhejiang Jianfeng Key News & Latest Developments
7.19 Beijing Winsunny Pharmaceutical
7.19.1 Beijing Winsunny Pharmaceutical Company Summary
7.19.2 Beijing Winsunny Pharmaceutical Business Overview
7.19.3 Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Major Product Offerings
7.19.4 Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Beijing Winsunny Pharmaceutical Key News & Latest Developments
8 Global Psychiatric and Nervous Drugs Production Capacity, Analysis
8.1 Global Psychiatric and Nervous Drugs Production Capacity, 2018-2029
8.2 Psychiatric and Nervous Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Psychiatric and Nervous Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Psychiatric and Nervous Drugs Supply Chain Analysis
10.1 Psychiatric and Nervous Drugs Industry Value Chain
10.2 Psychiatric and Nervous Drugs Upstream Market
10.3 Psychiatric and Nervous Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Psychiatric and Nervous Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Psychiatric and Nervous Drugs in Global Market
Table 2. Top Psychiatric and Nervous Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Psychiatric and Nervous Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Psychiatric and Nervous Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Psychiatric and Nervous Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Psychiatric and Nervous Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Psychiatric and Nervous Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Psychiatric and Nervous Drugs Product Type
Table 9. List of Global Tier 1 Psychiatric and Nervous Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psychiatric and Nervous Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Psychiatric and Nervous Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Psychiatric and Nervous Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Psychiatric and Nervous Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Psychiatric and Nervous Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Psychiatric and Nervous Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Psychiatric and Nervous Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Psychiatric and Nervous Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Psychiatric and Nervous Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Psychiatric and Nervous Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Psychiatric and Nervous Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Psychiatric and Nervous Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Psychiatric and Nervous Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Psychiatric and Nervous Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Psychiatric and Nervous Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Psychiatric and Nervous Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Psychiatric and Nervous Drugs Product Offerings
Table 48. Pfizer Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Ely Lilly Company Summary
Table 51. Ely Lilly Psychiatric and Nervous Drugs Product Offerings
Table 52. Ely Lilly Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Ely Lilly Key News & Latest Developments
Table 54. Actavis Company Summary
Table 55. Actavis Psychiatric and Nervous Drugs Product Offerings
Table 56. Actavis Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Actavis Key News & Latest Developments
Table 58. Mylan Company Summary
Table 59. Mylan Psychiatric and Nervous Drugs Product Offerings
Table 60. Mylan Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Mylan Key News & Latest Developments
Table 62. Randox Company Summary
Table 63. Randox Psychiatric and Nervous Drugs Product Offerings
Table 64. Randox Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Randox Key News & Latest Developments
Table 66. Intellipharmaceutics Company Summary
Table 67. Intellipharmaceutics Psychiatric and Nervous Drugs Product Offerings
Table 68. Intellipharmaceutics Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Intellipharmaceutics Key News & Latest Developments
Table 70. Astrazeneca Company Summary
Table 71. Astrazeneca Psychiatric and Nervous Drugs Product Offerings
Table 72. Astrazeneca Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Astrazeneca Key News & Latest Developments
Table 74. Lundbeck Company Summary
Table 75. Lundbeck Psychiatric and Nervous Drugs Product Offerings
Table 76. Lundbeck Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Lundbeck Key News & Latest Developments
Table 78. Allergan Company Summary
Table 79. Allergan Psychiatric and Nervous Drugs Product Offerings
Table 80. Allergan Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Allergan Key News & Latest Developments
Table 82. GSK Company Summary
Table 83. GSK Psychiatric and Nervous Drugs Product Offerings
Table 84. GSK Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. GSK Key News & Latest Developments
Table 86. Otsuka Pharmaceutical Company Summary
Table 87. Otsuka Pharmaceutical Psychiatric and Nervous Drugs Product Offerings
Table 88. Otsuka Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Otsuka Pharmaceutical Key News & Latest Developments
Table 90. Takeda Company Summary
Table 91. Takeda Psychiatric and Nervous Drugs Product Offerings
Table 92. Takeda Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Takeda Key News & Latest Developments
Table 94. NHU Group Company Summary
Table 95. NHU Group Psychiatric and Nervous Drugs Product Offerings
Table 96. NHU Group Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. NHU Group Key News & Latest Developments
Table 98. Shionogi Company Summary
Table 99. Shionogi Psychiatric and Nervous Drugs Product Offerings
Table 100. Shionogi Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Shionogi Key News & Latest Developments
Table 102. APOTEX Company Summary
Table 103. APOTEX Psychiatric and Nervous Drugs Product Offerings
Table 104. APOTEX Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. APOTEX Key News & Latest Developments
Table 106. Chengdu Kanghong Pharmaceutical Company Summary
Table 107. Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Product Offerings
Table 108. Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Chengdu Kanghong Pharmaceutical Key News & Latest Developments
Table 110. HUAHAI Company Summary
Table 111. HUAHAI Psychiatric and Nervous Drugs Product Offerings
Table 112. HUAHAI Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. HUAHAI Key News & Latest Developments
Table 114. Zhejiang Jianfeng Company Summary
Table 115. Zhejiang Jianfeng Psychiatric and Nervous Drugs Product Offerings
Table 116. Zhejiang Jianfeng Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Zhejiang Jianfeng Key News & Latest Developments
Table 118. Beijing Winsunny Pharmaceutical Company Summary
Table 119. Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Product Offerings
Table 120. Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Beijing Winsunny Pharmaceutical Key News & Latest Developments
Table 122. Psychiatric and Nervous Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global Psychiatric and Nervous Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Psychiatric and Nervous Drugs Production by Region, 2018-2023 (K Units)
Table 125. Global Psychiatric and Nervous Drugs Production by Region, 2024-2029 (K Units)
Table 126. Psychiatric and Nervous Drugs Market Opportunities & Trends in Global Market
Table 127. Psychiatric and Nervous Drugs Market Drivers in Global Market
Table 128. Psychiatric and Nervous Drugs Market Restraints in Global Market
Table 129. Psychiatric and Nervous Drugs Raw Materials
Table 130. Psychiatric and Nervous Drugs Raw Materials Suppliers in Global Market
Table 131. Typical Psychiatric and Nervous Drugs Downstream
Table 132. Psychiatric and Nervous Drugs Downstream Clients in Global Market
Table 133. Psychiatric and Nervous Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Psychiatric and Nervous Drugs Segment by Type in 2022
Figure 2. Psychiatric and Nervous Drugs Segment by Application in 2022
Figure 3. Global Psychiatric and Nervous Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Psychiatric and Nervous Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Psychiatric and Nervous Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Psychiatric and Nervous Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Psychiatric and Nervous Drugs Revenue in 2022
Figure 9. By Type - Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Psychiatric and Nervous Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Psychiatric and Nervous Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Psychiatric and Nervous Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
Figure 23. US Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
Figure 28. Germany Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
Figure 37. China Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Psychiatric and Nervous Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Psychiatric and Nervous Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Psychiatric and Nervous Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Psychiatric and Nervous Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Psychiatric and Nervous Drugs by Region, 2022 VS 2029
Figure 54. Psychiatric and Nervous Drugs Industry Value Chain
Figure 55. Marketing Channels
